FDA advisers consider time limit for bone drugs
From Reuters Health Information September 9, 2011 — ADELPHI, Md. (Reuters) – U.S. health advisers are considering a time limit for taking a class of drugs used by millions of women to prevent bone fractures, due to concerns over unusual fractures linked to the medicines and possible higher cancer rates. Two U.S. Food and Drug Administration … Read more